Alpha 2.0
Login Register
» Journals » Tohoku J Exp Med

The Tohoku Journal of Experimental Medicine

The Tohoku Journal of Experimental Medicine is a renowned scientific journal that publishes cutting-edge research in the field of experimental medicine. It covers a wide range of topics including molecular biology, genetics, immunology, pharmacology, and clinical medicine. With a focus on original research articles, this journal serves as a platform for scientists and researchers to share their findings and contribute to the advancement of medical knowledge.
Details
Abbr. Tohoku J Exp Med
Start 1920
End Continuing
Frequency Monthly
p-ISSN 0040-8727
e-ISSN 1349-3329
Country Japan
Language English
Specialty General Medicine
Metrics
h-index / Ranks: 5296 68
SJR / Ranks: 9147 484
CiteScore / Ranks: 7633 3.50
JIF / Ranks: 4835 2.2
Recent Articles
1.
Impacts of High-Intensity One-Year Respiratory Muscle Exercise on Respiratory Muscle Force and Dyspnea at Various Body Trunk Angles in a Tetraplegic Patient
Okazaki T, Takahashi R, Matsui T, Miyagi M, Miura T, Suzuki N, et al.
Tohoku J Exp Med . 2025 Mar; PMID: 40074347
No abstract available.
2.
LncRNA-CR848007.6 Affects Insulin Secretion by Regulating Cell Apoptosis and DNA Damage in Cadmium-Exposed Pancreatic β Cells and is a Novel Biomarker in Patients with Diabetes
Zhou Z, Zhou S, Guo H
Tohoku J Exp Med . 2025 Mar; PMID: 40074346
No abstract available.
3.
Wnt2 Expression in Cancer-Associated Fibroblasts Precedes Lymph Node Metastasis in Orthotopic Transplantation Mouse Model of Colorectal Cancer
Karasawa H, Murakami K, Miura K, Sasaki H, Ono T, Kajiwara T, et al.
Tohoku J Exp Med . 2025 Mar; PMID: 40074345
No abstract available.
4.
Clinical Significance and Biological Role of LncRNA HCG11 in Diabetic Retinopathy
Ling J, Ma J, Wu Z, Lin X, Zhu C, Xiao X
Tohoku J Exp Med . 2025 Mar; PMID: 40058849
No abstract available.
5.
Effects of Phosphodiesterase-3 Inhibitor in the Management of Left Heart Failure in Extremely Low-Birth-Weight Infants with Simple Aortic Coarctation
Hawaka H, Toyoshima K, Saito T, Shimokaze T, Tsuno K, Ikegawa T, et al.
Tohoku J Exp Med . 2025 Mar; PMID: 40058848
No abstract available.
6.
PLOD3 Promotes Head and Neck Squamous Cell Carcinoma Progress via Regulation of P38 MAPK Signal Pathway
Qiao J, Guo N, Wei C
Tohoku J Exp Med . 2025 Mar; PMID: 40058847
No abstract available.
7.
Berberine Improves ox-LDL-Induced Macrophage Efferocytosis Dysfunction and Alleviates Inflammation via the PPARγ/LXRα Pathway
Shen X, Chen Y, Yu L, Zheng J, Shang S, Wang J
Tohoku J Exp Med . 2025 Mar; PMID: 40058846
No abstract available.
8.
Formononetin Inhibits the Development of Lung Cancer by Targeting HK1 to Reduce Glycolysis Levels
Han J, Yuan Y
Tohoku J Exp Med . 2025 Feb; PMID: 40010748
No abstract available.
9.
The Effects of Cognitive Behavioral Stress Management on Loneliness, Spiritual Well-Being, Anxiety, and Depression in Patients with Unresectable Advanced Gastric Carcinoma: A Randomized, Controlled Study
Xia S
Tohoku J Exp Med . 2025 Feb; PMID: 40010747
No abstract available.
10.
Effect of Dexmedetomidine Plus Propofol versus Propofol Alone on Postoperative Anxiety and Depression, Efficacy, and Satisfaction in Patients who Undergo Painless Induced Abortion
Wei L, Li X, Li T, Dong Y, Zhang L
Tohoku J Exp Med . 2025 Feb; PMID: 40010746
No abstract available.